Diabetes Mellitus, Type 1

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Graz, Austria

• The University of Texas Medical Branch (UTMB) — Galveston, Texas, United States

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Neuss, Germany

• GSK Investigational Site — Cambridge, United Kingdom
• GSK Investigational Site — Cardiff, United Kingdom

• AMCR Institute, Inc. — Escondido, California, United States
• Scripps Whittier Diabetes Institute — La Jolla, California, United States
• Mills-Peninsula Health Services — San Mateo, California, United States
• Barbara Davis Center for Childhood Diabetes — Aurora, Colorado, United States

• LKH Salzburg/Universitätsklinikum der Paracelsus Med Privatuniversität/Innere Medizin I — Salzburg, Austria
• Universitair Ziekenhuis Antwerpen — Antwerp, Belgium
• AZ Imelda — Bonheiden, Belgium
• Fredericia Hospital — Fredericia, Denmark

• Centre Hospitalier Universitaire Jean Minjoz — Besançon, France
• Centre Hospitalier Universitaire — Caen, France
• Centre Hospitalier Sud-Francilien — Corbeil-Essonnes, France
• Centre Hospitalier Universitaire — Grenoble, France

Not specified

• University of Manitoba — Winnipeg, Manitoba, Canada

• AMCR Institute, Inc. — Escondido, California, United States
• Diabetes/Lipid Management and Research Center — Huntington Beach, California, United States
• National Research Institute — Los Angeles, California, United States
• Mills-Peninsula Health Services — San Mateo, California, United States